Peraso Inc. Income Taxes Disclosure
Note 8. Income Tax Provision
The income tax provision consisted of the following (in thousands):
| Year Ended December 31, | ||||||||
| 2024 | 2023 | |||||||
| Current portion: | ||||||||
| Federal and state | $ | $ | ||||||
| Deferred portion: | ||||||||
| Federal | (381 | ) | (2,545 | ) | ||||
| State | 83 | (1,392 | ) | |||||
| (298 | ) | (3,937 | ) | |||||
| Change in valuation allowance | 298 | 3,937 | ||||||
| Provision for income taxes | $ | $ | ||||||
Deferred income taxes reflect the net tax effects of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes.
Significant components of the Company’s deferred tax assets and liabilities were (in thousands):
| Year Ended December 31, | ||||||||
| 2024 | 2023 | |||||||
| Deferred tax assets: | ||||||||
| Federal and state loss carryforwards | $ | 4,732 | $ | 4,847 | ||||
| Reserves, accruals and other | 322 | 328 | ||||||
| Depreciation and amortization | 1,792 | 1,329 | ||||||
| Deferred stock-based compensation | 2,450 | 2,429 | ||||||
| Capitalized research and development costs | 595 | 660 | ||||||
| Research and development credit carryforwards | 6,744 | 6,744 | ||||||
| Total deferred tax assets | 16,635 | 16,337 | ||||||
| Less: Valuation allowance | (16,635 | ) | (16,337 | ) | ||||
| Net deferred tax assets, net | $ | $ | ||||||
Utilization of the Company’s net operating losses (NOLs) and tax credit carryforwards is subject to a substantial annual limitation due to the ownership change limitations provided by the Internal Revenue Code (IRC) and similar state provisions. Section 382 of the IRC (Section 382) imposes limitations on a corporation’s ability to utilize its NOL and tax credit carryforwards, if it experiences an “ownership change.” In general terms, an ownership change may result from transactions increasing the ownership percentage of certain stockholders in the stock of the corporation by more than 50% over a three-year period. In the event of an ownership change, utilization of the NOLs would be subject to an annual limitation under Section 382 determined by multiplying the value of the Company’s stock at the time of the ownership change by the applicable long-term tax-exempt rate. While a formal study has not been performed, the Company believes that Section 382 ownership changes occurred as a result of financing transaction in 2018 and the Arrangement. The Company believes the Section 382 limitations will result in approximately 91% of the federal and state NOLs expiring before they can be utilized, and approximately 94% of the federal tax credit carryforwards expiring before they can be utilized.
As of December 31, 2024, the Company had NOLs of approximately $212.1 million for federal income tax purposes and approximately $131.1 million for state income tax purposes. Only approximately $18.1 million of the federal NOLs and $13.3 million of the state NOLs are expected to be available before expiration due to the Section 382 limitation. These NOLs are available to reduce future taxable income and will expire at various times from 2025 through 2044, except federal NOLs from 2018 and later which have no expiration date. As of December 31, 2024, the Company also had federal research and development tax credit carryforwards of approximately $8.2 million that will expire at various times through 2044, and California research and development credits of approximately $8.5 million, which do not have an expiration date.
A reconciliation of income taxes provided at the federal statutory rate to the actual income tax provision is as follows (in thousands):
| Year Ended December 31, | ||||||||
| 2024 | 2023 | |||||||
| Income tax benefit computed at U.S. statutory rate | $ | 359 | $ | 277 | ||||
| Stock-based compensation | 9 | |||||||
| Amortization of intangible assets | (60 | ) | (60 | ) | ||||
| Change in fair value of warrant liabilities | (356 | ) | (734 | ) | ||||
| Valuation allowance changes affecting tax provision | 62 | 506 | ||||||
| Other | (5 | ) | 2 | |||||
| Income tax provision | $ | $ | ||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2024 | Mar 28, 2025 | Showing above |
| 2019 | Mar 17, 2020 | |
About Income Taxes Disclosures
The income tax disclosure reveals how much a company actually pays in taxes versus what the statutory rate would predict. Analysts focus on the effective tax rate (ETR) reconciliation, which breaks down every item driving the gap between the 21% federal rate and the company's reported ETR — including R&D credits, foreign rate differentials, and state taxes. Deferred tax assets (DTAs) and their valuation allowances signal management's confidence in future profitability: a rising allowance suggests the company doubts it can use accumulated tax benefits. Uncertain tax benefit (UTB) reserves quantify exposure to IRS challenges on aggressive positions.
Key signals to watch: sudden ETR drops without clear operational reasons, large increases in valuation allowances, growing UTB balances, and significant unremitted foreign earnings. Post-TCJA, pay attention to GILTI and BEAT provisions that affect multinational tax structures. Compare the cash taxes paid (from the cash flow statement) against the income tax provision to gauge earnings quality.